Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We describe a straightforward gene-targeting technique to achieve uniform, stable, and genetically invariant expression of a transgene in the vascular endothelium of mice. To demonstrate the feasibility of this approach, the reporter gene bacterial
beta-galactosidase
was inserted via homologous recombination into the intronless
thrombomodulin
locus of murine embryonic stem cells. In this fashion, the lacZ gene is placed under the regulatory control of the endogenous
thrombomodulin
promoter. The expression of the transgene in adult mice recapitulated the widespread, stable, and high-level expression of the
thrombomodulin
gene in vascular endothelium. These data indicate that targeting of cDNAs into the
thrombomodulin
locus serves as a viable strategy to express transgenes in endothelial cells. Analysis of reporter gene expression revealed a heterogeneous pattern of
thrombomodulin
gene activity in the endothelium of the aorta and its tributaries. We also show that embryonic stem cells with a targeted
thrombomodulin
locus contribute in a mosaic fashion to the vascular endothelium of chimeric mice. This method for generating animals with a functionally heterogeneous cardiovascular system should provide an experimental technique for studying how localized genetic abnormalities in endothelial cell function lead to the development of vascular diseases.
...
PMID:Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. 857 60
Embryonic lethality of
thrombomodulin
-deficient mice has indicated an essential role for this regulator of blood coagulation in murine development. Here, the embryonic expression pattern of
thrombomodulin
was defined by surveying
beta-galactosidase
activity in a mouse strain in which the reporter gene was placed under the regulatory control of the endogenous
thrombomodulin
promoter via homologous recombination in embryonic stem cells. The murine trophoblast was identified as a previously unrecognized anatomical site where TM expression is conserved between humans and mice and may exert a critical function during postimplantation development. Targeted reporter gene expression in mesodermal precursors of the endothelial cell lineage defined
thrombomodulin
as an early marker of vascular differentiation. Analysis of the
thrombomodulin
promoter in differentiating ES cells and in transgenic mice provided evidence for a disparate and cell type-specific gene regulatory control mechanism in the parietal yolk sac. The
thrombomodulin
promoter as defined in this study will allow the targeting of gene expression to the parietal yolk sac of transgenic mice and the initiation of investigations into the role of parietal endoderm in placental function.
...
PMID:Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. 868 7
The endothelium is morphologically and functionally adapted to meet the unique demands of the underlying tissue. At the present time, little is known about the molecular basis of endothelial cell diversity. As one approach to this problem, we have chosen to study the mechanisms that govern differential expression of the endothelial cell-restricted von Willebrand factor (vWF) gene. Transgenic mice were generated with a fragment of the vWF gene containing 2,182 bp of 5' flanking sequence, the first exon and first intron coupled to the LacZ reporter gene. In multiple independent lines of mice,
beta-galactosidase
expression was detected within endothelial cells in the brain, heart, and skeletal muscle. In isogeneic transplantation models, LacZ expression in host-derived auricular blood vessels was specifically induced by the microenvironment of the heart. In in vitro coculture assays, expression of both the transgene and the endogenous vWF gene in cardiac microvascular endothelial cells (CMEC) was upregulated in the presence of cardiac myocytes. In contrast, endothelial cell levels of
thrombomodulin
protein and mRNA were unchanged by the addition of ventricular myocytes. Moreover, CMEC expression of vWF was not influenced by the addition of 3T3 fibroblasts or mouse hepatocytes. Taken together, the results suggest that the vWF gene is regulated by vascular bed-specific pathways in response to signals derived from the local microenvironment.
...
PMID:Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. 928 88